Forest Fights Class Claims In Antidepressant Marketing MDL
Forest Laboratories on Friday struck back in multidistrict litigation alleging it misled consumers about the efficacy of its drugs Celexa and Lexapro in treating pediatric depression, telling a Massachusetts federal court...To view the full article, register now.
Already a subscriber? Click here to view full article